Neuroprotective agents: implications for Parkinson's disease treatment
Parkinson's disease (PD) is a multifaceted neurodegenerative condition marked by the progressive loss of dopaminergic neurons, leading to impairments in movement and cognition. This research offers an in-depth examination of the pathophysiological pathways associated with PD, emphasising the ro...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | en en en |
| Published: |
Bentham Science Publishers
2025
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/123820/7/123820_Neuroprotective%20agents_implications%20for%20Parkinson%27s.pdf http://irep.iium.edu.my/123820/8/123820_Neuroprotective%20agents_implications%20for%20Parkinson%27s_Scopus.pdf http://irep.iium.edu.my/123820/9/123820_Neuroprotective%20agents_implications%20for%20Parkinson%27s_WOS.pdf http://irep.iium.edu.my/123820/ https://www.eurekaselect.com/article/149681 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://irep.iium.edu.my/123820/7/123820_Neuroprotective%20agents_implications%20for%20Parkinson%27s.pdfhttp://irep.iium.edu.my/123820/8/123820_Neuroprotective%20agents_implications%20for%20Parkinson%27s_Scopus.pdf
http://irep.iium.edu.my/123820/9/123820_Neuroprotective%20agents_implications%20for%20Parkinson%27s_WOS.pdf
http://irep.iium.edu.my/123820/
https://www.eurekaselect.com/article/149681
